I'll have to look into it more, the claims are complicated, but I do take exception with this:
"The problem is, if you look at those large, aggregate models, and remove just this single study, ivermectin loses almost all of its purported benefit. Take the
recent meta-analysis by Bryant et al. that has been all over the news — they found a 62% reduction in risk of death for people who were treated with ivermectin compared to controls when combining randomized trials.
However, if you remove the Elgazzar paper from their model, and rerun it, the benefit goes from 62% to 52%, and largely loses its statistical significance. There’s no benefit seen whatsoever for people who have severe COVID-19, and the confidence intervals for people with mild and moderate disease become extremely wide"
First of all, no one had ever said it works on people with severe COVID, it's a prophylactic, it prevents the infection from taking place, it can't fight an infection that's already there.
Second, 52% is a big deal to me, I don't understand why they're saying 62% is amazing but 52% is equal to "loses almost all of its purported benefit."
But I'll check the rest out. I haven't paid attention to all this for a while so I don't have everything to hand, but if I can muster the energy I'll check out some of the old Peak Prosperity videos on the info and studies that have come out and post the data.
As I recall, you really have to take it in the first 48 hours to get the benefit, and it doesn't work once you're quite sick. That's always been the case, and any study that only tests people already 2 days into symptoms will find little benefit. As I recall, it binds to the site that COVID wants to bind to, I think that's it.